Grants and Contributions:
Title:
Injectable Medical Device
Agreement Number:
928515
Agreement Value:
$134,059.00
Agreement Date:
May 1, 2019 - Mar 12, 2022
Description:
BIOMATCAN is emerging into the bone regenerative industry with unique innovative technology and products to meet the increasing demand in the market with innovative solutions for bone augmentation and reconstructive surgery. The project aims to develop an injectable formulation of bone substitute biomaterlals.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Fredericton, New Brunswick, CA E3B 5N6
Reference Number:
172-2019-2020-Q2-928515
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
807577267
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 82 days.
Amendment Date
Jan 18, 2022
Recipient's Operating Name:
BiomATCan Ltd.
Recipient's Legal Name:
BiomATCan Ltd.
Federal Riding Name:
Fredericton
Federal Riding Number:
13003
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
339110
Amendments: